Serological detection of varicella-zoster virus-specific immunoglobulin G by an enzyme-linked immunosorbent assay using glycoprotein antigen

Journal of Clinical Microbiology

Volumn 44, Issue 9, 2006, Pages 3094-3097

  Sauerbrei, A ^a   Wutzler, P ^a  

^a JENA UNIVERSITY HOSPITAL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CELL ANTIGEN; CHICKENPOX VACCINE; HERPES ZOSTER IMMUNOGLOBULIN; IMMUNOGLOBULIN G; IMMUNOGLOBULIN G ANTIBODY; MEMBRANE ANTIGEN; VARICELLA ZOSTER VACCINE; VIRUS ENVELOPE PROTEIN; VIRUS GLYCOPROTEIN;

ANTIBODY DETECTION; ANTIBODY RESPONSE; ARTICLE; CHICKENPOX; ENZYME LINKED IMMUNOSORBENT ASSAY; FLUORESCENT ANTIBODY TECHNIQUE; FLUORESCENT ANTIBODY TO MEMBRANE ANTIGEN ASSAY; HUMAN; IMMUNE STATUS; LATENT VIRUS INFECTION; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; QUANTITATIVE ASSAY; SENSITIVITY AND SPECIFICITY; VACCINATION; VARICELLA ZOSTER VIRUS;

ANTIBODIES, VIRAL; ANTIBODY SPECIFICITY; ANTIGENS, VIRAL; CHICKENPOX; ENZYME-LINKED IMMUNOSORBENT ASSAY; GLYCOPROTEINS; HERPES ZOSTER; HERPESVIRUS 3, HUMAN; HUMANS; IMMUNOGLOBULIN G; REAGENT KITS, DIAGNOSTIC; SENSITIVITY AND SPECIFICITY; VIRAL PROTEINS;

HUMAN HERPESVIRUS 3;

EID: 33748776045     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/JCM.00719-06     Document Type: Article

References (24)

1. Balfour, H. H., Jr., C. K. Edelman, C. L. Dirksen, D. R. Palermo, C. S. Suarez, J. Kelly, J. T. Kentala, and D. D. Crane. 1988. Laboratory studies of acute varicella and varicella immune status. Diagn. Microbiol. Infect. Dis. 10:149-158.
2. Demmler, G. L., S. P. Steinberg, G. Blum, and A. A. Gershon. 1988. Rapid enzyme-linked immunosorbent assay for detecting antibody to varicella-zoster virus. J. Infect. Dis. 157:211-212.
3. Gallagher, J., B. Quaid, and B. Cryan. 1996. Susceptibility to varicella-zoster virus infection in health care workers. Occup. Med. 46:289-292.
4. Gershon, A. A., R. Raker, S. Steinberg, B. Topf-Olstein, and L. M. Drusin. 1976. Antibody to varicella-zoster virus in parturient women and their offspring during the first year of life. Pediatrics 58:692-696.
5. Hayward, A. R., G. O. Zerbe, and M. J. Levin. 1994. Clinical application of responder cell frequency estimates with four years of follow up. J. Immunol. Methods 170:27-36.
6. Health Canada. 2002. National Advisory Committee on Immunization (NACI): update to statement on varicella vaccine. CCDR 28:1-8.
7. Krah, D. L. 1996. Assays for antibodies to varicella-zoster virus. Infect. Dis. Clin. N. Am. 10:507-527.
8. Krah, D. L., I. Cho, T. Schofield, and R. W. Ellis. 1997. Comparison of gpELISA and neutralizing antibody responses to Oka/Merck live varicella vaccine (Varivax) in children and adults. Vaccine 15:61-64.
9. Krasinski, K., R. Holzman, R. La Couture, and A. L. Florman. 1986. Hospital experience with varicella-zoster virus. Infect. Control 7:312-316.
10. Maple, P. A. C., J. Gray, J. Breuer, G. Kafatos, S. Parker, and D. Brown. 2006. Performance of a time-resolved fluorescence immunoassay for measuring varicella-zoster virus immunoglobulin G levels in adults and comparison with commercial enzyme immunoassays and Merck glycoprotein enzyme immunoassay. Clin. Vaccine Immunol. 13:214-218.
11. Morales-Castillo, M. E., M. T. Alvarez-Munoz, F. Solorzano-Santos, R. Gonzalez-Robledo, L. Jasso-Gutierrez, and O. Munoz-Hernandez. 2000. Live varicella vaccine in both immunocompromised and healthy children. Arch. Med. Res. 31:85-87.
12. Provost, P. J., D. L. Krah, B. J. Kuter, D. H. Morton, T. L. Schofield, E. H. Wasmuth, C. J. White, W. J. Miller, and R. W. Ellis. 1991. Antibody assays suitable for assessing immune response to live varicella vaccine. Vaccine 9:111-116.
13. Robert Koch-Institut. 2001. Mitteilung der Ständigen Impfkommission (STIKO) am Robert Koch-Institut. Fragen und Antworten zu verschiedenen Impfungen. Epidemiol. Bull. 8:58.
14. Robert Koch-Institut. 2004. Empfehlungen der Ständigen Impfkommission (STIKO) am RKI (Stand Juli 2004). Epidemiol. Bull. 30:235-250.
15. Saiman, L., P. LaRussa, S. P. Steinberg, J. Zhou, K. Baron, S. Whittier, P. Della-Latta, and A. A. Gershon. 2001. Persistence of immunity to varicella-zoster virus after vaccination of healthcare workers. Infect. Control Hosp. Epidemiol. 22:279-283.
16. Sauerbrei, A., U. Eichhorn, G. Hottenrott, and P. Wutzler. 2000. Virological diagnosis of herpes simplex encephalitis. J. Clin. Virol. 17:31-36.
17. Sauerbrei, A., I. Färber, A. Brandstädt, M. Schacke, and P. Wutzler. 2004. Immunofluorescence test for highly sensitive detection of varicella-zoster virus-specific IgG: alternative to fluorescent antibody to membrane antigen test. J. Virol. Methods 119:25-30.
18. Sauerbrei, A., and P. Wutzler. 2004. Varicella-Zoster-Virus-Infektionen: Aktuelle Prophylaxe und Therapie. Uni-Med, Bremen, Germany.
19. Sauerbrei, A., and P. Wutzler. 2005. Varicella-zoster virus infections during pregnancy: epidemiology, clinical symptoms, diagnosis, prevention and therapy. Curr. Pediatr. Rev. 1:205-216.
20. Steinberg, S. P., and A. A. Gershon. 1991. Measurement of antibodies to varicella-zoster virus by using a latex agglutination test. J. Clin. Microbiol. 29:1527-1529.
21. Wasmuth, E. H., and W. Miller. 1990. Sensitive enzyme-linked immunosorbent assay for antibody to varicella-zoster virus using purified VZV glycoprotein antigen. J. Med. Virol. 32:189-193.
22. Weinberg, A., A. R. Hayward, H. B. Masters, I. A. Ogu, and M. J. Levin. 1996. Comparison of two methods for detecting varicella-zoster virus antibody with varicella-zoster virus cell-mediated immunity. J. Clin. Microbiol. 34:445-446.
23. Wutzler, P., I. Färber, S. Wagenpfeil, H. Bisanz, and A. Tischer. 2002. Seroprevalence of varicella-zoster virus in the German population. Vaccine 21:121-124.
24. Zaia, J. A., and M. N. Oxman. 1977. Antibody to varicella-zoster virus-induced membrane antigen: immunofluorescence assay using monodisperse glutaraldehyde-fixed target cells. J. Infect. Dis. 156:519-530.